Legal & General Group Plc Takes Position in Ralliant Corporation $RAL

Legal & General Group Plc acquired a new stake in Ralliant Corporation (NYSE:RAL) during the second quarter, according to its most recent filing with the SEC. The firm acquired 249,207 shares of the company’s stock, valued at approximately $18,349,000. Legal & General Group Plc owned about 0.23% of Ralliant as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in RAL. The Manufacturers Life Insurance Company acquired a new position in Ralliant during the 2nd quarter valued at about $7,351,000. Group One Trading LLC bought a new position in Ralliant in the second quarter valued at approximately $36,000. Algert Global LLC lifted its stake in shares of Ralliant by 439.9% in the 2nd quarter. Algert Global LLC now owns 126,010 shares of the company’s stock valued at $9,278,000 after purchasing an additional 102,670 shares during the period. Barrow Hanley Mewhinney & Strauss LLC acquired a new position in shares of Ralliant in the 2nd quarter valued at $8,493,000. Finally, Globeflex Capital L P bought a new position in shares of Ralliant in the 2nd quarter worth $623,000.

Analyst Upgrades and Downgrades

RAL has been the topic of a number of recent analyst reports. Zacks Research upgraded Ralliant from a “hold” rating to a “strong-buy” rating in a report on Tuesday, June 30th. Vertical Research cut shares of Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price objective for the company. in a report on Wednesday, May 27th. Morgan Stanley lifted their price target on shares of Ralliant from $68.00 to $85.00 and gave the stock an “overweight” rating in a research report on Tuesday, June 23rd. Truist Financial reissued a “buy” rating and issued a $82.00 price target (up from $68.00) on shares of Ralliant in a report on Friday, July 31st. Finally, BMO Capital Markets started coverage on Ralliant in a report on Monday, July 20th. They set a “market perform” rating and a $78.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $75.70.

Insider Buying and Selling at Ralliant

In related news, SVP Karen M. Bick sold 6,062 shares of Ralliant stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $72.00, for a total value of $436,464.00. Following the sale, the senior vice president owned 31,668 shares of the company’s stock, valued at approximately $2,280,096. The trade was a 16.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Tamara S. Newcombe sold 12,936 shares of the company’s stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $71.79, for a total value of $928,675.44. Following the sale, the chief executive officer owned 251,967 shares in the company, valued at $18,088,710.93. The trade was a 4.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.42% of the stock is currently owned by insiders.

Ralliant Trading Down 0.1%

NYSE RAL opened at $61.65 on Monday. The stock has a market capitalization of $6.82 billion, a price-to-earnings ratio of -5.68, a PEG ratio of 2.29 and a beta of 1.61. The stock’s 50 day moving average price is $68.40 and its two-hundred day moving average price is $56.53. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.00 and a current ratio of 1.52. Ralliant Corporation has a 52 week low of $37.27 and a 52 week high of $75.41.

Ralliant (NYSE:RAL) last released its quarterly earnings results on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, topping analysts’ consensus estimates of $0.63 by $0.05. The firm had revenue of $567.80 million during the quarter. Ralliant had a positive return on equity of 14.97% and a negative net margin of 56.38%.Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, analysts anticipate that Ralliant Corporation will post 2.87 earnings per share for the current fiscal year.

Ralliant Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a $0.05 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Ralliant’s dividend payout ratio (DPR) is -1.84%.

Ralliant Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.